PubMed · 1992 · 262 citations · 0 references
Life SciencesInfectious DiseasesMolecular VirologyVaccinologyVirologyAntiretroviral TherapyAntiviral ImmunityHiv Vaccine DevelopmentViral GeneticsViral InfectionsViral VaccinesAntiviral TherapeuticsChimeric Monoclonal AntibodiesChimeric Viral VectorsHiv Envelope Glycoprotein AntigensHiv Infection ModelsTherapeutic Hiv VaccinesViral Envelope Glycoproteins
Replication competent chimeric viruses that express the gag and pol proteins of SIVmac and the env proteins of HIV-1 were made. One such chimeric virus, SHIV-4, that expresses the vif, vpx, vpr, and nef regulatory genes of SIV and the tat and rev regulatory genes of HIV-1 replicated efficiently in cynomolgus monkeys. This model system can be used to evaluate the efficacy of anti-HIV-1 vaccines directed at the envelope glycoproteins, anti-HIV-1 envelope glycoprotein antiserum or monoclonal antibodies, and anti-HIV-1 drugs designed to inhibit the tat, rev, or env functions.